Targeted macrophages delivery of rifampicin-loaded lipid nanoparticles to improve tuberculosis treatment
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeted macrophages delivery of rifampicin-loaded lipid nanoparticles to improve tuberculosis treatment
Authors
Keywords
-
Journal
Nanomedicine
Volume 12, Issue 24, Pages 2721-2736
Publisher
Future Medicine Ltd
Online
2017-11-09
DOI
10.2217/nnm-2017-0248
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Functionalization promotes pathogen-mimicking characteristics of polyanhydride nanoparticle adjuvants
- (2017) Yashdeep Phanse et al. JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
- The formulation of nanomedicines for treating tuberculosis
- (2016) Ana Costa et al. ADVANCED DRUG DELIVERY REVIEWS
- Getting into the brain: liposome-based strategies for effective drug delivery across the blood–brain barrier
- (2016) Débora Vieira et al. International Journal of Nanomedicine
- Current applications of nanoparticles in infectious diseases
- (2016) Hinojal Zazo et al. JOURNAL OF CONTROLLED RELEASE
- The Importance of First Impressions: Early Events in Mycobacterium tuberculosis Infection Influence Outcome
- (2016) Anthony M. Cadena et al. mBio
- Design of a nanostructured lipid carrier intended to improve the treatment of tuberculosis
- (2016) Marina Pinheiro et al. Drug Design Development and Therapy
- Self-Assembled Nanoparticles Based on Amphiphilic Anticancer Drug–Phospholipid Complex for Targeted Drug Delivery and Intracellular Dual-Controlled Release
- (2015) Yang Li et al. ACS Applied Materials & Interfaces
- Self-Targeted, Shape-Assisted, and Controlled-Release Self-Delivery Nanodrug for Synergistic Targeting/Anticancer Effect of Cytoplasm and Nucleus of Cancer Cells
- (2015) Yang Li et al. ACS Applied Materials & Interfaces
- Orthogonally Functionalized Nanoscale Micelles for Active Targeted Codelivery of Methotrexate and Mitomycin C with Synergistic Anticancer Effect
- (2015) Yang Li et al. MOLECULAR PHARMACEUTICS
- Tuberculosis treatment and management—an update on treatment regimens, trials, new drugs, and adjunct therapies
- (2015) Alimuddin Zumla et al. Lancet Respiratory Medicine
- Simulated Biological Fluids with Possible Application in Dissolution Testing
- (2015) Margareth R. C. Marques et al. DISSOLUTION TECHNOLOGIES
- Freeze-Dried Targeted Mannosylated Selenium-Loaded Nanoliposomes: Development and Evaluation
- (2013) Susanne R. Youngren et al. AAPS PHARMSCITECH
- State of the art and future directions in nanomedicine for tuberculosis
- (2013) Admire Dube et al. Expert Opinion on Drug Delivery
- Conference Scene: From innovative polymers to advanced nanomedicine: key challenges, recent progress and future perspectives
- (2013) Jan Feijen et al. Nanomedicine
- Advances in the development of new tuberculosis drugs and treatment regimens
- (2013) Alimuddin Zumla et al. NATURE REVIEWS DRUG DISCOVERY
- Freeze-drying of nanostructure lipid carriers by different carbohydrate polymers used as cryoprotectants
- (2012) Jaleh Varshosaz et al. CARBOHYDRATE POLYMERS
- Macrophages and control of granulomatous inflammation in tuberculosis
- (2011) J L Flynn et al. Mucosal Immunology
- Liposomes as drug delivery systems for the treatment of TB
- (2011) Marina Pinheiro et al. Nanomedicine
- The systemic toxicity of positively charged lipid nanoparticles and the role of Toll-like receptor 4 in immune activation
- (2010) Ranit Kedmi et al. BIOMATERIALS
- Mannosylated solid lipid nanoparticles as vectors for site-specific delivery of an anti-cancer drug
- (2010) Ashay Jain et al. JOURNAL OF CONTROLLED RELEASE
- Mannose-targeted systems for the delivery of therapeutics
- (2008) Juan M Irache et al. Expert Opinion on Drug Delivery
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started